Transcaruncular orbital decompression for management of XXXX in thyroid-related orbitopathy.

@entity1 @entity892 @entity1781 @entity6
This study was conducted to assess the outcome of transcaruncular orbital decompression to treat @entity1781 in thyroid-related orbitopathy. It involved a retrospective, noncomparative case series of 18 eyes of 10 consecutive @entity1 with documented vision loss secondary to thyroid-related orbitopathy. Bony decompression of the orbital apex was performed via a transcaruncular approach. Main outcome measures were visual acuity, color vision, presence of @entity892 , and reduction of exophthalmos. Of 18 eyes, 16 (89 percent) had improved visual acuity after the operation. One eye had no improvement and one had worsening of vision in the setting of @entity6 . Color vision was improved in 12 eyes (67 percent). Five of the @entity1 did not have @entity892 before the operation; none of these @entity1 developed @entity892 after intervention. Exophthalmos was decreased by an average of 2.6 mm. The authors conclude that transcaruncular orbital decompression for @entity1781 in thyroid-related orbitopathy is successful in restoring visual function. Compared with other approaches used for decompression surgery, the transcaruncular approach offers direct access to the medial wall and orbital apex without a cutaneous incision or disruption of the medial canthus. In addition, this approach allows a controlled, graded removal of the ethmoidal air cells and reduced recovery time.
